JP2009532332A5 - - Google Patents

Download PDF

Info

Publication number
JP2009532332A5
JP2009532332A5 JP2008557569A JP2008557569A JP2009532332A5 JP 2009532332 A5 JP2009532332 A5 JP 2009532332A5 JP 2008557569 A JP2008557569 A JP 2008557569A JP 2008557569 A JP2008557569 A JP 2008557569A JP 2009532332 A5 JP2009532332 A5 JP 2009532332A5
Authority
JP
Japan
Prior art keywords
skin
granzyme
reduce
subject
rate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008557569A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009532332A (ja
JP5746813B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2007/000396 external-priority patent/WO2007101354A1/en
Publication of JP2009532332A publication Critical patent/JP2009532332A/ja
Publication of JP2009532332A5 publication Critical patent/JP2009532332A5/ja
Application granted granted Critical
Publication of JP5746813B2 publication Critical patent/JP5746813B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008557569A 2006-03-09 2007-03-09 皮膚の老化の外観を処置、低減及び抑制する方法 Expired - Fee Related JP5746813B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US78035206P 2006-03-09 2006-03-09
US60/780,352 2006-03-09
US79735206P 2006-05-04 2006-05-04
US60/797,352 2006-05-04
PCT/CA2007/000396 WO2007101354A1 (en) 2006-03-09 2007-03-09 Methods of treating, reducing and inhibiting the appearance of ageing in the skin

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013112324A Division JP2013173794A (ja) 2006-03-09 2013-05-28 皮膚の老化の外観を処置、低減及び抑制する方法

Publications (3)

Publication Number Publication Date
JP2009532332A JP2009532332A (ja) 2009-09-10
JP2009532332A5 true JP2009532332A5 (https=) 2010-04-30
JP5746813B2 JP5746813B2 (ja) 2015-07-08

Family

ID=38474579

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2008557569A Expired - Fee Related JP5746813B2 (ja) 2006-03-09 2007-03-09 皮膚の老化の外観を処置、低減及び抑制する方法
JP2013112324A Pending JP2013173794A (ja) 2006-03-09 2013-05-28 皮膚の老化の外観を処置、低減及び抑制する方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013112324A Pending JP2013173794A (ja) 2006-03-09 2013-05-28 皮膚の老化の外観を処置、低減及び抑制する方法

Country Status (6)

Country Link
US (1) US20120171144A1 (https=)
EP (1) EP2002012A4 (https=)
JP (2) JP5746813B2 (https=)
CA (1) CA2644664C (https=)
NZ (1) NZ571858A (https=)
WO (1) WO2007101354A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8426149B2 (en) * 2007-10-01 2013-04-23 The University Of British Columbia Granzyme A and granzyme B diagnostics
WO2009055934A1 (en) * 2007-11-02 2009-05-07 The University Of British Columbia Treatment of fibrillinopathy or elastinopathy using granzyme inhibitors
CA2819810A1 (en) * 2010-12-06 2012-06-14 The University Of British Columbia Granzyme b inhibitor compositions, methods and uses for promoting wound healing
WO2014153666A1 (en) * 2013-03-29 2014-10-02 Vida Therapeutics, Inc. Indoline compounds as granzyme b inhibitors
US9605021B2 (en) 2013-03-29 2017-03-28 Vida Therapeutics Inc. Indoline compounds as granzyme B inhibitors
JP6305727B2 (ja) * 2013-10-31 2018-04-04 ポーラ化成工業株式会社 皮膚光老化防止用組成物
US9458192B1 (en) 2014-08-01 2016-10-04 Vida Therapeutics Inc. Covalent granzyme B inhibitors
WO2016015159A1 (en) 2014-08-01 2016-02-04 Vida Therapeutics, Inc. Azaindoline compounds as granzyme b inhibitors
US9458138B1 (en) 2014-08-01 2016-10-04 viDATherapeutics Inc. Pyrrole compounds as granzyme B inhibitors
US9458193B1 (en) 2014-08-01 2016-10-04 Vida Therapeutics Inc. Proline compounds as Granzyme B inhibitors
AU2015296675B2 (en) 2014-08-01 2020-04-30 Vida Therapeutics, Inc. Cyclic urea compounds as Granzyme B inhibitors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000136122A (ja) * 1998-10-28 2000-05-16 Kose Corp 皮膚外用剤
EP1163900A1 (en) * 1998-11-05 2001-12-19 Protease Sciences, Incorporated Cosmetic compositions containing human type serine protease inhibitors
JP2002537346A (ja) * 1999-02-22 2002-11-05 エリック・エフ・バーンスタイン 光老化の保護用組成物および保護方法
US6699486B1 (en) * 1999-11-18 2004-03-02 Bolla Corporation Treatment or prevention of photoaging and skin cancer
US7326692B2 (en) * 2001-11-14 2008-02-05 The University Of Chicago Induction of immunity using inhibitors of granzymes
EP1474093A4 (en) * 2002-02-04 2005-02-16 Merck & Co Inc Granzyme B INHIBITORS
JP2004075661A (ja) * 2002-06-18 2004-03-11 Shiseido Co Ltd 表皮基底膜ケアを特徴とする皮膚外用剤、皮膚基底膜構造形成促進剤および人工皮膚の製造方法

Similar Documents

Publication Publication Date Title
JP2009532332A5 (https=)
RU2605300C2 (ru) Способ оценки косметических средств
WO2007041331A3 (en) Mucosal sensor for the assessment of tissue and blood constituents and technique for using the same
Marco et al. Does skin hydration influence keratinocyte biology? In vivo evaluation of microscopic skin changes induced by moisturizers by means of reflectance confocal microscopy
WO2010067212A3 (en) A complex of active vegetal stem cells and a cosmetic composition
DE50107916D1 (de) Dreidimensionales hautmodell
WO2011091244A1 (en) Methods to treat or prevent a skin condition using a nell1 peptide
CN1930473B (zh) 以角质层中的氧化蛋白质为指标的角质层的透明性的评价方法
JP2011525495A5 (https=)
WO2016065688A1 (zh) 一种能激活肌肤活力和抗衰老的精华液
JP2012502289A5 (https=)
Chamberlain et al. Cutaneous melanoma: atypical variants and presentations
WO2008066949A3 (en) Total covariance signal processor using sample matrix inversion and side lobe cancellation
WO2011011677A3 (en) Method for detecing/enriching trichogenic dermal cells, cells and use thereof in method of treatment of hair loss
WO2008108155A1 (ja) 抗シワ物質の評価法及び皮膚の鑑別法
WO2007046038A3 (en) Cosmetic method for use in smoothing the skin
Roberts et al. Skin hydration-a key determinant in topical absorption
EA200800722A1 (ru) Средство, активирующее стволовые клетки и/или клетки-предшественники
GB2419186C (en) Method to measure the effect of topically applied agents using skin maintained in organ culture.
Lemoine et al. Role of 70-kDa ribosomal protein S6 kinase, nitric oxide synthase, glycogen synthase kinase-3β, and mitochondrial permeability transition pore in desflurane-induced postconditioning in isolated human right atria
Lakshmanachetty et al. Emerging roles for collagen XV and XVIII in cancer progression.
Bonetti Development of standardized procedures to evaluate morphological, mechanical and physical properties of nails and their alterations: Pharmaceutical and cosmetics applications
Song et al. 1315 An Integrated model of alopecia areata biomarkers highlights both Th1/Th2 upregulation, with stronger correlations between Th2 activation and disease severity
Shin et al. 1314 Advanced age impairs self-renewal and biases fate choice of hair follicle dermal stem cells
JP2005170805A (ja) スキンケア化粧料とその化粧料セット、並びにそれらの使用方法